Y-Biologics

 

About Y-Biologics

Wai Bio Logics is representing the Republic of Korea antibody company specialized in antibody drug since its inception has focused on research and development. Based on the research and development that began in 2007, we have successfully built our unique human antibody library Y-max ABL, a new dual antibody platform technology ALiCE, and based on this, we have developed a variety of new antibody drugs to become a leader in the global market for cancer drugs. Every effort is made to leap.

Therapeutic Areas

Other

Technologies

Other

Company Type

Biotechnology – R&D services

State of Ownership

Private

Sponsorship Group

Networker